InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Processa Pharmaceuticals, Inc.

PCSA Clue Score47
United States Fiscal year ends December CIK 0001533743
$1.90 +25.00% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.90 −76.80% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 10 Oct 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−1.9Net income−1.9EPS, diluted−0.07Fiscal year 2017Operating income−1.8Net income−1.9EPS, diluted−0.06Fiscal year 2018Operating income−4.5Net income−3.8Fiscal year 2019Operating income−3.9Net income−3.4Fiscal year 2020Operating income−15.1Net income−14.4Fiscal year 2021Revenue0.0Operating income−12.1Net income−11.4Fiscal year 2022Revenue0.0Operating income−27.5Net income−27.4EPS, diluted−34.05Fiscal year 2023Operating income−11.5Net income−11.1EPS, diluted−8.48Fiscal year 2024Operating income−12.1Net income−11.9EPS, diluted−96.78Fiscal year 2025Operating income−14.0Net income−13.6EPS, diluted−10.36
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 n/a n/a n/a n/a 0.0 0.0 n/a n/a n/a
Growth
Operating income −1.9 −1.8 −4.5 −3.9 −15.1 −12.1 −27.5 −11.5 −12.1 −14.0
Net income −1.9 −1.9 −3.8 −3.4 −14.4 −11.4 −27.4 −11.1 −11.9 −13.6
Growth
EPS, diluted −0.07 −0.06 n/a n/a n/a n/a −34.05 −8.48 −96.78 −10.36

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin100.0%Operating margin−38,430.4%Net margin−38,341.3%Free cash flow margin−43,576.2%Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 100.0% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating margin −38,430.4% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net margin −38,341.3% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free cash flow margin −43,576.2% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−2.2Capital expenditure−0.0Free cash flow−2.2Fiscal year 2017Operating cash flow−1.7Capital expenditure−0.0Free cash flow−1.7Fiscal year 2018Operating cash flow−3.7Fiscal year 2019Operating cash flow−2.8Fiscal year 2020Operating cash flow−3.1Fiscal year 2021Operating cash flow−8.7Fiscal year 2022Operating cash flow−9.6Fiscal year 2023Operating cash flow−8.1Capital expenditure−0.0Free cash flow−8.1Fiscal year 2024Operating cash flow−11.2Capital expenditure−0.0Free cash flow−11.2Fiscal year 2025Operating cash flow−11.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.2 −1.7 −3.7 −2.8 −3.1 −8.7 −9.6 −8.1 −11.2 −11.4
Capital expenditure −0.0 −0.0 n/a n/a n/a n/a n/a −0.0 −0.0 n/a
Free cash flow −2.2 −1.7 n/a n/a n/a n/a n/a −8.1 −11.2 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash1.1Shareholders’ equity−2.3Fiscal year 2017Cash2.8Shareholders’ equity0.4Fiscal year 2018Cash1.7Shareholders’ equity9.7Fiscal year 2019Cash0.7Shareholders’ equity8.0Fiscal year 2020Cash15.4Shareholders’ equity22.9Fiscal year 2021Cash16.5Shareholders’ equity25.5Fiscal year 2022Cash6.5Shareholders’ equity7.5Fiscal year 2023Cash4.7Shareholders’ equity5.0Fiscal year 2024Cash1.2Shareholders’ equity1.7Fiscal year 2025Cash5.5Shareholders’ equity5.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.1 2.8 1.7 0.7 15.4 16.5 6.5 4.7 1.2 5.5
Shareholders’ equity −2.3 0.4 9.7 8.0 22.9 25.5 7.5 5.0 1.7 5.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
0.0 n/a n/a n/a n/a 0.0 0.0 n/a n/a n/a
Growth
0.0 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Growth
1.5 1.0 3.1 2.3 3.2 6.9 11.5 5.8 n/a n/a
0.1 0.8 1.4 1.6 3.3 4.7 8.8 5.7 4.8 6.2
−1.9 −1.8 −4.5 −3.9 −15.1 −12.1 −27.5 −11.5 −12.1 −14.0
Growth
−0.3 −1.9 −4.7 −4.0 −15.4 −12.0 −27.4 −11.1 −11.9 −13.6
n/a 0.3 −0.9 −0.6 −1.0 −0.5 n/a n/a n/a n/a
−1.9 −1.9 −3.8 −3.4 −14.4 −11.4 −27.4 −11.1 −11.9 −13.6
Growth
Per share
−0.07 −0.06 n/a n/a n/a −0.75 −34.05 −8.48 −96.78 −10.36
−0.07 −0.06 n/a n/a n/a n/a −34.05 −8.48 −96.78 −10.36
Growth
29.3 32.6 n/a n/a n/a 15.3 0.8 1.3 0.1 1.3
29.3 32.6 n/a n/a n/a n/a 0.8 1.3 0.1 1.3
Growth +11.2% +62.8% −90.7% +969.3%

† The diluted share count jumps at 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.